Provided By GlobeNewswire
Last update: Mar 11, 2024
Oak Ridge, TN, March 11, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today announces the expansion of blood volume analysis (BVA) in three new hospitals through new analyzer purchases, and the utilization of Daxor’s ezBVA Lab service. These new acquisitions further fuel BVA sales growth and underscore its clinical relevance.
NASDAQ:DXR (10/24/2025, 8:20:19 PM)
13.78
+0.18 (+1.32%)
Find more stocks in the Stock Screener


